Invite: Expert Access: Barclays Hosted: KOL Call with HIMS Competitor to Discuss GLP-1 Reacceleration in 2H, International Expansion, & New Therapeutic Areas

Research evidence excerpt

Invite: Expert Access: Barclays Hosted: KOL Call with HIMS Competitor to Discuss GLP-1 Reacceleration in 2H, International Expansion, & New Therapeutic Areas

maker and/or liquidity provider, underwriter, distributor, index sponsor, swap counterparty and

calculation agent) simultaneously with respect to a product, giving rise to potential conflicts of

interest which may impact the performance of a product.

BARCLAYS POSITIONS

Barclays may at any time acquire, hold or dispose of long or short positions (including hedging and

trading positions) and trade or otherwise effect transactions for their own account or the account of

their customers in the products referred to herein which may impact the performance of a product.

FOR INFORMATION ONLY

THIS DOCUMENT IS PROVIDED FOR INFORMATION PURPOSES ONLY AND IT IS SUBJECT TO CHANGE.

This information has been prepared by the Research Department within the Investment Bank of

Barclays. The information, analytic tools, and/or models referenced herein (and any reports or results

derived from their use) are intended for informational purposes only. Barclays has no obligation to

update this information and may cease provision of this information at any time and without notice.

NO OFFER

Barclays is not offering to sell or seeking offers to buy any product or enter into any transaction. Any

offer or entry into any transaction requires Barclays’ subsequent formal agreement which will be

subject to internal approvals and execution of binding transaction documents. The products

mentioned may not be eligible for sale in some states or countries, nor suitable for all types of

investors. Without limitation to the foregoing, any transaction may also be subject to review by

Barclays Group against its published Tax Principles.

NO LIABILITY